Welcome
Support Centre
24 October 2014 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Concomitant Biceps Tenodesis in Primary Shoulder Arthroplasty for Primary Osteoarthritis - A Randomised Controlled Study
ISRCTN ISRCTN71203361
DOI 10.1186/ISRCTN71203361
ClinicalTrials.gov identifier
EudraCT number
Public title Concomitant Biceps Tenodesis in Primary Shoulder Arthroplasty for Primary Osteoarthritis - A Randomised Controlled Study
Scientific title
Acronym N/A
Serial number at source N0227186094
Study hypothesis What is the effect of concomitant biceps tenodesis in primary shoulder arthroplasty done for primary osteoarthritis? Does it improve or worsen the pain relief and function of the new shoulder joint or it has no effect? This project aims to produce a level I evidence for this question at 2 and 5 years follow up.
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Musculoskeletal Diseases: Osteoarthritis
Participants - inclusion criteria The study intends to examine all the patients with painful, primary degenerative glenohumeral joint who are listed to undergo a Primary Shoulder Replacement. It would involve patients from both sexes and all age groups. We have not sought for any statistical help yet for calculating the required sample size. It is expected to include at least 25 patients from each of the two operation groups. Statistical consultation has been requested.
Participants - exclusion criteria 1. Patients with rheumatoid or other inflammatory arthritis
2. Patients who had previous operations for trauma or infection in the same joint
3. Neurovascular problems
4. Revision operations
5. Patients with history of previous instability problems of the shoulder
6. Patients with rotator cuff deficiency
7. Patients with previous biceps tendon rupture
8. However, the patient or assessor would be kept blind to whether concomitant biceps tenodesis procedure is performed.
Anticipated start date 01/02/2006
Anticipated end date 01/02/2011
Status of trial Completed
Patient information material
Target number of participants 50
Interventions DESIGN OF STUDY - This is a prospective randomised controlled study recruiting patients who have been wait listed for primary shoulder replacement operation for primary shoulder osteoarthrosis at JCUH. These patients will be given all the information about the study at least 2 weeks prior to operation and those patients willing to participate in the study will be consented and recruited into the study.

PILOT STUDY - Since the surgeon is experienced and has been performing biceps tenodesis in addition to shoulder replacement operations in certain selected cases, the pilot study has not been planned.

TRIAL PHASE - Once the trial phase begins all the patients who are listed as candidates for primary shoulder operation for Primary Osteoarthritis are assessed by an independent observer in the clinic. The patients are given information leaflet about the condition he or she has got, about the study being performed and blinded allocation of patients into two groups "with or without concomitant biceps tenodesis at the time of Primary shoulder replacement operation". Any questions from the patients will also be clarified. Address and telephone number for further help and information is also given in the information leaflet. For selecting the surgical procedure, a blinded randomisation will be performed using the SPSS soft ware (SPSS, Chicago, IL). The code of the procedure (1. Concomitant Biceps tenodesis 2. No concomitant biceps tenodesis) will be revealed to surgeon at the time of operation. The anaesthesia, surgical approach, post operative pain management and rehabilitation will be exactly same between both groups. A standardised prostair is used in all cases. Tenodesis of long head of biceps is only an additional step, where in the tendon will be divided and sutured into its bony tunnel, around its sheath by means of 2-3 interrupted non absorbable sutures. This step of operation needs no additional exposure of the wound nor it takes longer than 3-4 mins when performed. Patients and the single independent observer will be blinded as to the procedure performed until the end of the study. Patients are followed up at 6 weeks, 3 months, 6 months post op and yearly thereafter. All the clinical and radiographic data documented in a specifically designed data collection form. Data will be regularly entered into spread sheets using SPSS software. Analysis of the various demographic, functional and radiological data including Oxford and Constant scores will be done at 1 year, 2 years, 5 years follow up.

SURGEONS PERFORMING THE PROCEDURES - The number of surgeons performing to the procedure will be limited to 2-3 over the study period and all operations will be performed in the presence of a senior consultant orthopaedic surgeon at JCUH.
Primary outcome measure(s) During the pre op and various stages of post operative phases, demographic details will be collected. A patient questionnaire (based on Oxford score) which will give information about pain and functional abilities.Assessment using Constant and Murley score which looks at assessment of daily activities (score), assessment of external rotation and internal rotation (score for each movement), assessment of forward elevation and lateral elevation (score for various degrees of movement), pain level (scored 0, 5, 10, 15), level of raising the hand (up to waist, xiphoid, neck, up to the head, above the head, unable to move shoulder), shoulder power (measured by a special device).
Secondary outcome measure(s) Not provided at time of registration
Sources of funding South Tees Hospitals NHS Trust (UK)
Trial website
Publications
Contact name Mr  Amar  Rangan
  Address Orthopaedics
Middlesbrough General Hospital
  City/town Middlesbrough
  Zip/Postcode TS5 5AZ
  Country United Kingdom
Sponsor Record Provided by the NHSTCT Register - 2007 Update - Department of Health
  Address The Department of Health, Richmond House, 79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Fax +44
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 28/09/2007
Last edited 27/06/2013
Date ISRCTN assigned 28/09/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2014 ISRCTN unless otherwise stated.